▲ BUY
7
/ 10
Conviction
$ Value
—
Shares
4,860
Price
—
Filed
Mar 24
▶ Why this score? (7/10)
- ✓ Open market buy (+3)
- ✓ Director (+1)
- ✓ Cluster: 3 insiders buying (+2)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
Marton Laurence
Title
—
CIK
0001862192
Roles
Director
Transaction Details
Transaction Date
2026-03-20
Code
P
Table
Derivative
Ownership
Indirect
Equity Swap
No
Shares After
4,860
Footnotes
The securities were purchased in a private placement on March 20, 2026 for an aggregate of $10,000. | The warrants are exercisable immediately upon issuance and expire on the earlier of (i) March 30, 2029 or (ii) 30 days following the date the Issuer reports at least $1.5 million in product sales revenue (excluding licensing fees, upfront milestones and grants, but including royalty revenue from product sales) for any calendar quarter in a quarterly or annual report.
Filing Info
Marton Laurence's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-20 | RNXT | ▲ | — |
| 2026-03-20 | RNXT | ▲ | — |
| 2025-10-01 | RNXT | A | $0 |
| 2025-05-02 | RNXT | M | $3K |
| 2025-05-02 | RNXT | M | $0 |
Other Insiders at RNXT (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
VOLL MARK
Chief Financial Officer
|
— | — | 2026-04-03 |
| Marton Laurence | — | — | 2026-03-20 |
|
Bagai Shaun
Chief Executive Officer
|
— | — | 2026-04-03 |
|
Agah Ramtin
Chief Medical Officer
|
— | — | 2026-04-03 |
|
Gentry Leesa
Chief Clinical Officer
|
— | — | 2026-04-03 |